The Duke Human Vaccine Institute

The Duke Human Vaccine Institute (DHVI) is a globally recognized leader in the research and development of vaccines and therapeutics against major infectious diseases. Located in Durham, North Carolina, at 2 Genome Ct, and with an additional location at 27 Alexandria Way, Durham, North Carolina 27703, US, the institute plays a vital role in the Global HIV/AIDS Vaccine Enterprise and is at the forefront of research into emerging infections and biodefense.

By targeting scientific obstacles in the creation of effective vaccines and therapeutics for diseases like HIV, influenza, and SARS-CoV-2, The Duke Human Vaccine Institute is dedicated to making significant contributions to global health. The institute's commitment to innovation, collaboration, and excellence drives its efforts to address pressing global health challenges and improve outcomes for populations worldwide.

The Duke Human Vaccine Institute is committed to developing vaccines and therapeutics against diseases of global importance while training the next generation of scientists. With a focus on respect, integrity, and safety, DHVI embraces change and cultivates diversity to achieve synergy in its research endeavors. The Duke Human Vaccine Institute is poised to continue its impactful work in vaccine and therapeutic development. We invite the management team to create a customized and exclusive company showcase and product listing on our platform, highlighting your organization's pivotal contributions to global health.